Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prothena Corp Public (PRTA) EBIT (2016 - 2025)

Prothena Corp Public (PRTA) has 14 years of EBIT data on record, last reported at -$24.2 million in Q4 2025.

  • For Q4 2025, EBIT rose 62.71% year-over-year to -$24.2 million; the TTM value through Dec 2025 reached -$214.6 million, down 38.87%, while the annual FY2025 figure was -$214.6 million, 38.87% down from the prior year.
  • EBIT reached -$24.2 million in Q4 2025 per PRTA's latest filing, up from -$40.2 million in the prior quarter.
  • Across five years, EBIT topped out at $109.2 million in Q3 2021 and bottomed at -$84.6 million in Q2 2025.
  • Average EBIT over 5 years is -$31.0 million, with a median of -$41.7 million recorded in 2022.
  • Peak YoY movement for EBIT: soared 454.1% in 2021, then crashed 108948.61% in 2023.
  • A 5-year view of EBIT shows it stood at -$33.1 million in 2021, then skyrocketed by 99.78% to -$72000.0 in 2022, then plummeted by 108948.61% to -$78.5 million in 2023, then increased by 17.34% to -$64.9 million in 2024, then skyrocketed by 62.71% to -$24.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$24.2 million in Q4 2025, -$40.2 million in Q3 2025, and -$84.6 million in Q2 2025.